Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Anumigilimab biosimilar, Whole mAb, Anti-CSF3R/G-CSF-R Antibody: Anti-CD114/GCSFR/SCN7 therapeutic antibody |
Anumigilimab |
NA |
CSF3R |
Whole mAb |
||
Pre-Made Bafisontamab biosimilar, Whole mAb, Anti-EGFR;MET Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody |
Bafisontamab |
NA |
EGFR,MET |
Bispecific Mixed mAb and Fab |
||
Pre-Made Barzolvolimab biosimilar, Whole mAb, Anti-KIT Antibody: Anti-C-Kit/CD117/MASTC/PBT/SCFR therapeutic antibody |
Barzolvolimab |
NA |
KIT |
Whole mAb |
||
Pre-Made Beludavimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Beludavimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Dalutrafusp biosimilar, Whole mAb, Anti-TGFBR2 Antibody: Anti-AAT3/FAA3/LDS1B/LDS2/LDS2B/MFS2/RIIC/TAAD2/TBR-ii/TBRII/TGFR-2-RII therapeutic antibody |
Dalutrafusp |
NA |
TGFBR2 |
Whole mAb Fusion |
||
Pre-Made Dresbuxelimab biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody: Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic antibody |
Dresbuxelimab |
NA |
NT5E |
Whole mAb |
||
Pre-Made Eblasakimab biosimilar, Whole mAb, Anti-IL13RA1 Antibody: Anti-CD213A1/CT19/IL-13Ra/NR4 therapeutic antibody |
Eblasakimab |
NA |
IL13RA1 |
Whole mAb |
||
Pre-Made Ecleralimab biosimilar, Whole Mab: Anti-TSLP therapeutic antibody |
Ecleralimab |
NA |
TSLP |
Whole mAb |
||
Pre-Made Elranatamab biosimilar, Whole mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Elranatamab |
NA |
TNFRSF17,CD3E |
Bispecific Whole mAb |
||
Pre-Made Ensomafusp Biosimilar, Fusion Protein targeting CD19: Recombinant therapeutic protein targeting B4/CVID3 |
Ensomafusp |
NA |
CD19 |
Fusion Protein |
||
Pre-Made Enuzovimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Enuzovimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Fidasimtamab biosimilar, Whole mAb, Anti-PDCD1/PD-1;ERBB2/HER2 Antibody: Anti-CD279/PD1/SLEB2/hSLE1;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody |
Fidasimtamab |
NA |
PDCD1,ERBB2 |
Bispecific Whole mAb |
||
Pre-Made Galegenimab biosimilar, Whole mAb, Anti-HTRA1 Antibody: Anti-ARMD7/CADASIL2/CARASIL/HtrA/L56/ORF480/PRSS11 therapeutic antibody |
Galegenimab |
NA |
HTRA1 |
Whole mAb |
||
Pre-Made Ginisortamab biosimilar, Whole mAb, Anti-GREM1/Gremlin-1 Antibody: Anti-C15DUPq/CKTSF1B1/CRAC1/CRCS4/DAND2/DRM/DUP15q/GREMLIN/HMPS/HMPS1/IHG-2/MPSH/PIG2 therapeutic antibody |
Ginisortamab |
NA |
GREM1 |
Whole mAb |
||
Pre-Made Gresonitamab biosimilar, Whole mAb, Anti-CLDN18;CD3E Antibody: Anti-SFTA5/SFTPJ;T3E/TCRE/IMD18 therapeutic antibody |
Gresonitamab |
NA |
CLDN18,CD3E |
Bispecific scFv-scFv-scFc |
||
Pre-Made Gumokimab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody |
Gumokimab |
NA |
IL17A |
Whole mAb |
||
Pre-Made Iparomlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Iparomlimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Ivicentamab biosimilar, Whole mAb, Anti-CD37;CD37 Antibody: Anti-GP52-40/TSPAN26;GP52-40/TSPAN26 therapeutic antibody |
Ivicentamab |
NA |
CD37,CD37 |
Bispecific/biparatopic |
||
Pre-Made Ivonescimab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody |
Ivonescimab |
NA |
VEGFA |
scFv-IGHC |
||
Pre-Made Lepunafusp biosimilar, Whole mAb, Anti-TfR1/TFRC Antibody: Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 therapeutic antibody |
Lepunafusp |
NA |
TfR1 |
Whole mAb Fusion |
||
Pre-Made Ligufalimab biosimilar, Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6 therapeutic antibody |
Ligufalimab |
NA |
CD47 |
Whole mAb |
||
Pre-Made Livmoniplimab biosimilar, Whole mAb, Anti-LRRC32 Antibody: Anti-CPPRDD/D11S833E/GARP therapeutic antibody |
Livmoniplimab |
NA |
LRRC32 |
Whole mAb |
||
Pre-Made Lomtegovimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Lomtegovimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Lorigerlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1;CTLA4/CTLA-4 Antibody: Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody |
Lorigerlimab |
NA |
PDCD1,CTLA4 |
Bispecific Mixed scFv (scFv-CH2-CH3-scFv) |
||
Pre-Made Manfidokimab biosimilar, Whole mAb, Anti-IL4R Antibody: Anti-CD124 therapeutic antibody |
Manfidokimab |
NA |
IL4R |
Whole mAb |
||
Pre-Made Mazorelvimab biosimilar, Whole Mab: Anti-Rabies Virus Spike Glycoprotein G therapeutic antibody |
Mazorelvimab |
NA |
Rabies Virus Spike Glycoprotein G |
Whole mAb |
||
Pre-Made Melredableukin biosimilar, Whole Mab: Anti-Non-Binding therapeutic antibody |
Melredableukin |
NA |
Non-Binding |
Whole mAb Fusion |
||
Pre-Made Mupadolimab biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody: Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic antibody |
Mupadolimab |
NA |
NT5E |
Whole mAb |
||
Pre-Made Nofazinlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Nofazinlimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Ormutivimab biosimilar, Whole Mab: Anti-Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 therapeutic antibody |
Ormutivimab |
NA |
Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 |
Whole mAb |
||
Pre-Made Pivekimab biosimilar, Whole mAb, Anti-IL3RA Antibody: Anti-IL3R/CD123/IL3RX/IL3RY/hIL-3Ra therapeutic antibody |
Pivekimab |
NA |
IL3RA |
Whole mAb |
||
Pre-Made Pulocimab biosimilar, Whole mAb, Anti-VEGFR2/KDR Antibody: Anti-CD309/FLK1/VEGFR therapeutic antibody |
Pulocimab |
NA |
VEGFR2 |
Whole mAb |
||
Pre-Made Quisovalimab biosimilar, Whole mAb, Anti-TNFSF14/CD258 Antibody: Anti-HVEML/LIGHT/LTg therapeutic antibody |
Quisovalimab |
NA |
TNFSF14 |
Whole mAb |
||
Pre-Made Rimteravimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Rimteravimab |
NA |
SARS-CoV-2 Spike RBD |
Mixed Nanobody (VHH-CH2-CH3 dimer) |
||
Pre-Made Rocatinlimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody |
Rocatinlimab |
NA |
TNFRSF4 |
Whole mAb |
||
Pre-Made Romlusevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Romlusevimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Rulonilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Rulonilimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Simridarlimab biosimilar, Whole mAb, Anti-CD47;CD274/PD-L1 Antibody: Anti-IAP/OA3/MER6;B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1 therapeutic antibody |
Simridarlimab |
NA |
CD47,CD274 |
Bispecific Mixed mAb/VH-VH-CH2-CH3 |
||
Pre-Made Sirexatamab biosimilar, Whole mAb, Anti-DKK1 Antibody: Anti-SK/DKK-1 therapeutic antibody |
Sirexatamab |
NA |
DKK1 |
Whole mAb |
||
Pre-Made Socazolimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Socazolimab |
NA |
CD274 |
Whole mAb |
||
Pre-Made Sotevtamab biosimilar, Whole mAb, Anti-CLU/Clusterinm Antibody: Anti-AAG4/APO-J/APOJ/CLI/KUB1/NA1/NA2/SGP-2/SGP2/SP-40/TRPM-2/TRPM2 therapeutic antibody |
Sotevtamab |
NA |
CLU |
Whole mAb |
||
Pre-Made Suciraslimab biosimilar, Whole mAb, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody |
Suciraslimab |
NA |
CD22 |
Whole mAb |
||
Pre-Made Tagitanlimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Tagitanlimab |
NA |
CD274 |
Whole mAb |
||
Pre-Made Tamgiblimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody |
Tamgiblimab |
NA |
TIGIT |
Whole mAb |
||
Pre-Made Tarcolimab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody |
Tarcolimab |
NA |
VEGFA |
Whole mAb |
||
Pre-Made Tecaginlimab biosimilar, Whole mAb, Anti-CD40;TNFRSF9/CD137 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5;ILA/4-1BB/CDw137 therapeutic antibody |
Tecaginlimab |
NA |
CD40,TNFRSF9 |
Bispecific Whole mAb |
||
Pre-Made Teropavimab biosimilar, Whole Mab: Anti-HIV-1 gp120 CD4bs therapeutic antibody |
Teropavimab |
NA |
HIV-1 gp120 CD4bs |
Whole mAb |
||
Pre-Made Trinbelimab biosimilar, Whole mAb, Anti-RhD Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody |
Trinbelimab |
NA |
RHD |
Whole mAb |
||
Pre-Made Tuvonralimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody |
Tuvonralimab |
NA |
CTLA4 |
Whole mAb |
||
Pre-Made Ubamatamab biosimilar, Whole mAb, Anti-MUC16;CD3E Antibody: Anti-CA125;T3E/TCRE/IMD18 therapeutic antibody |
Ubamatamab |
NA |
MUC16,CD3E |
Bispecific Whole mAb |
